MS Treatment Is on the Cusp of Something Big: On the Cusp of Something Big?

Abstract

For so long, multiple sclerosis has frustrated physicians and patients. With bold new treatments on the way, payers are thinking about tighter management. Formal treatment guidelines would help. Bio-markers could also sort out the 'right-drug, right-patient' conundrum.